A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers
Ocellaris Pharma, Inc.
Ocellaris Pharma, Inc.
Actym Therapeutics, Inc.
Elevation Oncology
Seagen Inc.
Sotio Biotech Inc.
ADC Therapeutics S.A.
Fusion Pharmaceuticals Inc.
pharmaand GmbH
Genmab
MacroGenics
National Institutes of Health Clinical Center (CC)
Tocagen Inc.
Seagen Inc.
National Institutes of Health Clinical Center (CC)
CureOne
Celldex Therapeutics
National Institutes of Health Clinical Center (CC)
Millennium Pharmaceuticals, Inc.